People

Emily James
Emily James is listed by Cambridge Innovation Capital as analyst. Life-sciences analyst with a Cambridge doctorate in pathology focused on immune oncology and earlier AstraZeneca research experience. This affiliation follows CIC’s published directory; other career appointments are scoped to its biography and do not imply personal investment tickets.
Roles
Cambridge Innovation Capital
CurrentAnalyst